 | • レポートコード：MRC2Q12-16832 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、プリオン病治療薬の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にプリオン病治療薬のグローバル市場のxxx％を占める「抗うつ薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 プリオン病治療薬の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのプリオン病治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 プリオン病治療薬のグローバル主要プレイヤーには、Novartis AG、Merck KGaA、Aurobindo Pharma、AstraZeneca、Abbott、Ionis Pharmaceuticals、Lannett、Astellas Pharma Inc.、Sawai Pharmaceutical、Elite Pharmaceuticals, Inc.、Teva Pharmaceuticals、Bristol Myers Squibbなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 プリオン病治療薬市場は、種類と用途によって区分されます。世界のプリオン病治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 抗うつ薬、抗精神病薬、その他 【用途別セグメント】 病院、薬局、オンライン薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - プリオン病治療薬製品概要 - 種類別市場（抗うつ薬、抗精神病薬、その他） - 用途別市場（病院、薬局、オンライン薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のプリオン病治療薬販売量予測2017-2028 - 世界のプリオン病治療薬売上予測2017-2028 - プリオン病治療薬の地域別販売量 - プリオン病治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別プリオン病治療薬販売量 - 主要メーカー別プリオン病治療薬売上 - 主要メーカー別プリオン病治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（抗うつ薬、抗精神病薬、その他） - プリオン病治療薬の種類別販売量 - プリオン病治療薬の種類別売上 - プリオン病治療薬の種類別価格 ・用途別市場規模（病院、薬局、オンライン薬局、その他） - プリオン病治療薬の用途別販売量 - プリオン病治療薬の用途別売上 - プリオン病治療薬の用途別価格 ・北米市場 - 北米のプリオン病治療薬市場規模（種類別、用途別） - 主要国別のプリオン病治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのプリオン病治療薬市場規模（種類別、用途別） - 主要国別のプリオン病治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のプリオン病治療薬市場規模（種類別、用途別） - 主要国別のプリオン病治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のプリオン病治療薬市場規模（種類別、用途別） - 主要国別のプリオン病治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのプリオン病治療薬市場規模（種類別、用途別） - 主要国別のプリオン病治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Novartis AG、Merck KGaA、Aurobindo Pharma、AstraZeneca、Abbott、Ionis Pharmaceuticals、Lannett、Astellas Pharma Inc.、Sawai Pharmaceutical、Elite Pharmaceuticals, Inc.、Teva Pharmaceuticals、Bristol Myers Squibb ・産業チェーン及び販売チャネル分析 - プリオン病治療薬の産業チェーン分析 - プリオン病治療薬の原材料 - プリオン病治療薬の生産プロセス - プリオン病治療薬の販売及びマーケティング - プリオン病治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - プリオン病治療薬の産業動向 - プリオン病治療薬のマーケットドライバー - プリオン病治療薬の課題 - プリオン病治療薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Prion Disease Drug estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Prion Disease Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Prion Disease Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Prion Disease Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Prion Disease Drug include Novartis AG, Merck KGaA, Aurobindo Pharma, AstraZeneca, Abbott, Ionis Pharmaceuticals, Lannett, Astellas Pharma Inc. and Sawai Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Prion Disease Drug companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Prion Disease Drug market. Further, it explains the major drivers and regional dynamics of the global Prion Disease Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Novartis AG
Merck KGaA
Aurobindo Pharma
AstraZeneca
Abbott
Ionis Pharmaceuticals
Lannett
Astellas Pharma Inc.
Sawai Pharmaceutical
Elite Pharmaceuticals, Inc.
Teva Pharmaceuticals
Bristol Myers Squibb
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Prion Disease Drug Segment by Type
Antidepressant
Antipsychotic Agents
Others
Prion Disease Drug Segment by Application
Hospital
Pharmacies
Online Pharmacies
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Prion Disease Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Prion Disease Drug market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Prion Disease Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prion Disease Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prion Disease Drug revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Prion Disease Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Prion Disease Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, Merck KGaA, Aurobindo Pharma, AstraZeneca, Abbott, Ionis Pharmaceuticals, Lannett, Astellas Pharma Inc. and Sawai Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prion Disease Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prion Disease Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prion Disease Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prion Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antidepressant
1.2.3 Antipsychotic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prion Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prion Disease Drug Market Perspective (2017-2028)
2.2 Prion Disease Drug Growth Trends by Region
2.2.1 Prion Disease Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prion Disease Drug Historic Market Size by Region (2017-2022)
2.2.3 Prion Disease Drug Forecasted Market Size by Region (2023-2028)
2.3 Prion Disease Drug Market Dynamics
2.3.1 Prion Disease Drug Industry Trends
2.3.2 Prion Disease Drug Market Drivers
2.3.3 Prion Disease Drug Market Challenges
2.3.4 Prion Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prion Disease Drug Players by Revenue
3.1.1 Global Top Prion Disease Drug Players by Revenue (2017-2022)
3.1.2 Global Prion Disease Drug Revenue Market Share by Players (2017-2022)
3.2 Global Prion Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prion Disease Drug Revenue
3.4 Global Prion Disease Drug Market Concentration Ratio
3.4.1 Global Prion Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prion Disease Drug Revenue in 2021
3.5 Prion Disease Drug Key Players Head office and Area Served
3.6 Key Players Prion Disease Drug Product Solution and Service
3.7 Date of Enter into Prion Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prion Disease Drug Breakdown Data by Type
4.1 Global Prion Disease Drug Historic Market Size by Type (2017-2022)
4.2 Global Prion Disease Drug Forecasted Market Size by Type (2023-2028)
5 Prion Disease Drug Breakdown Data by Application
5.1 Global Prion Disease Drug Historic Market Size by Application (2017-2022)
5.2 Global Prion Disease Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prion Disease Drug Market Size (2017-2028)
6.2 North America Prion Disease Drug Market Size by Type
6.2.1 North America Prion Disease Drug Market Size by Type (2017-2022)
6.2.2 North America Prion Disease Drug Market Size by Type (2023-2028)
6.2.3 North America Prion Disease Drug Market Share by Type (2017-2028)
6.3 North America Prion Disease Drug Market Size by Application
6.3.1 North America Prion Disease Drug Market Size by Application (2017-2022)
6.3.2 North America Prion Disease Drug Market Size by Application (2023-2028)
6.3.3 North America Prion Disease Drug Market Share by Application (2017-2028)
6.4 North America Prion Disease Drug Market Size by Country
6.4.1 North America Prion Disease Drug Market Size by Country (2017-2022)
6.4.2 North America Prion Disease Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Prion Disease Drug Market Size (2017-2028)
7.2 Europe Prion Disease Drug Market Size by Type
7.2.1 Europe Prion Disease Drug Market Size by Type (2017-2022)
7.2.2 Europe Prion Disease Drug Market Size by Type (2023-2028)
7.2.3 Europe Prion Disease Drug Market Share by Type (2017-2028)
7.3 Europe Prion Disease Drug Market Size by Application
7.3.1 Europe Prion Disease Drug Market Size by Application (2017-2022)
7.3.2 Europe Prion Disease Drug Market Size by Application (2023-2028)
7.3.3 Europe Prion Disease Drug Market Share by Application (2017-2028)
7.4 Europe Prion Disease Drug Market Size by Country
7.4.1 Europe Prion Disease Drug Market Size by Country (2017-2022)
7.4.2 Europe Prion Disease Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prion Disease Drug Market Size (2017-2028)
8.2 Asia-Pacific Prion Disease Drug Market Size by Type
8.2.1 Asia-Pacific Prion Disease Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prion Disease Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prion Disease Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Prion Disease Drug Market Size by Application
8.3.1 Asia-Pacific Prion Disease Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prion Disease Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prion Disease Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Prion Disease Drug Market Size by Region
8.4.1 Asia-Pacific Prion Disease Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prion Disease Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prion Disease Drug Market Size (2017-2028)
9.2 Latin America Prion Disease Drug Market Size by Type
9.2.1 Latin America Prion Disease Drug Market Size by Type (2017-2022)
9.2.2 Latin America Prion Disease Drug Market Size by Type (2023-2028)
9.2.3 Latin America Prion Disease Drug Market Share by Type (2017-2028)
9.3 Latin America Prion Disease Drug Market Size by Application
9.3.1 Latin America Prion Disease Drug Market Size by Application (2017-2022)
9.3.2 Latin America Prion Disease Drug Market Size by Application (2023-2028)
9.3.3 Latin America Prion Disease Drug Market Share by Application (2017-2028)
9.4 Latin America Prion Disease Drug Market Size by Country
9.4.1 Latin America Prion Disease Drug Market Size by Country (2017-2022)
9.4.2 Latin America Prion Disease Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prion Disease Drug Market Size (2017-2028)
10.2 Middle East & Africa Prion Disease Drug Market Size by Type
10.2.1 Middle East & Africa Prion Disease Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prion Disease Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prion Disease Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Prion Disease Drug Market Size by Application
10.3.1 Middle East & Africa Prion Disease Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prion Disease Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prion Disease Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Prion Disease Drug Market Size by Country
10.4.1 Middle East & Africa Prion Disease Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prion Disease Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Prion Disease Drug Introduction
11.1.4 Novartis AG Revenue in Prion Disease Drug Business (2017-2022)
11.1.5 Novartis AG Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Prion Disease Drug Introduction
11.2.4 Merck KGaA Revenue in Prion Disease Drug Business (2017-2022)
11.2.5 Merck KGaA Recent Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma Prion Disease Drug Introduction
11.3.4 Aurobindo Pharma Revenue in Prion Disease Drug Business (2017-2022)
11.3.5 Aurobindo Pharma Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Prion Disease Drug Introduction
11.4.4 AstraZeneca Revenue in Prion Disease Drug Business (2017-2022)
11.4.5 AstraZeneca Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Prion Disease Drug Introduction
11.5.4 Abbott Revenue in Prion Disease Drug Business (2017-2022)
11.5.5 Abbott Recent Developments
11.6 Ionis Pharmaceuticals
11.6.1 Ionis Pharmaceuticals Company Details
11.6.2 Ionis Pharmaceuticals Business Overview
11.6.3 Ionis Pharmaceuticals Prion Disease Drug Introduction
11.6.4 Ionis Pharmaceuticals Revenue in Prion Disease Drug Business (2017-2022)
11.6.5 Ionis Pharmaceuticals Recent Developments
11.7 Lannett
11.7.1 Lannett Company Details
11.7.2 Lannett Business Overview
11.7.3 Lannett Prion Disease Drug Introduction
11.7.4 Lannett Revenue in Prion Disease Drug Business (2017-2022)
11.7.5 Lannett Recent Developments
11.8 Astellas Pharma Inc.
11.8.1 Astellas Pharma Inc. Company Details
11.8.2 Astellas Pharma Inc. Business Overview
11.8.3 Astellas Pharma Inc. Prion Disease Drug Introduction
11.8.4 Astellas Pharma Inc. Revenue in Prion Disease Drug Business (2017-2022)
11.8.5 Astellas Pharma Inc. Recent Developments
11.9 Sawai Pharmaceutical
11.9.1 Sawai Pharmaceutical Company Details
11.9.2 Sawai Pharmaceutical Business Overview
11.9.3 Sawai Pharmaceutical Prion Disease Drug Introduction
11.9.4 Sawai Pharmaceutical Revenue in Prion Disease Drug Business (2017-2022)
11.9.5 Sawai Pharmaceutical Recent Developments
11.10 Elite Pharmaceuticals, Inc.
11.10.1 Elite Pharmaceuticals, Inc. Company Details
11.10.2 Elite Pharmaceuticals, Inc. Business Overview
11.10.3 Elite Pharmaceuticals, Inc. Prion Disease Drug Introduction
11.10.4 Elite Pharmaceuticals, Inc. Revenue in Prion Disease Drug Business (2017-2022)
11.10.5 Elite Pharmaceuticals, Inc. Recent Developments
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Details
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Prion Disease Drug Introduction
11.11.4 Teva Pharmaceuticals Revenue in Prion Disease Drug Business (2017-2022)
11.11.5 Teva Pharmaceuticals Recent Developments
11.12 Bristol Myers Squibb
11.12.1 Bristol Myers Squibb Company Details
11.12.2 Bristol Myers Squibb Business Overview
11.12.3 Bristol Myers Squibb Prion Disease Drug Introduction
11.12.4 Bristol Myers Squibb Revenue in Prion Disease Drug Business (2017-2022)
11.12.5 Bristol Myers Squibb Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Prion Disease Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antidepressant
Table 3. Key Players of Antipsychotic Agents
Table 4. Key Players of Others
Table 5. Global Prion Disease Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Prion Disease Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Prion Disease Drug Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Prion Disease Drug Market Share by Region (2017-2022)
Table 9. Global Prion Disease Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Prion Disease Drug Market Share by Region (2023-2028)
Table 11. Prion Disease Drug Market Trends
Table 12. Prion Disease Drug Market Drivers
Table 13. Prion Disease Drug Market Challenges
Table 14. Prion Disease Drug Market Restraints
Table 15. Global Prion Disease Drug Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Prion Disease Drug Revenue Share by Players (2017-2022)
Table 17. Global Top Prion Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prion Disease Drug as of 2021)
Table 18. Ranking of Global Top Prion Disease Drug Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Prion Disease Drug Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prion Disease Drug Product Solution and Service
Table 22. Date of Enter into Prion Disease Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prion Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Prion Disease Drug Revenue Market Share by Type (2017-2022)
Table 26. Global Prion Disease Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Prion Disease Drug Revenue Market Share by Type (2023-2028)
Table 28. Global Prion Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Prion Disease Drug Revenue Share by Application (2017-2022)
Table 30. Global Prion Disease Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Prion Disease Drug Revenue Share by Application (2023-2028)
Table 32. North America Prion Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Prion Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Prion Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Prion Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Prion Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Prion Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Prion Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Prion Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Prion Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Prion Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Prion Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Prion Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Prion Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Prion Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Prion Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Prion Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Prion Disease Drug Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Prion Disease Drug Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Prion Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Prion Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Prion Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Prion Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Prion Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Prion Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Prion Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Prion Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Prion Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Prion Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Prion Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Prion Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Prion Disease Drug Product
Table 65. Novartis AG Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 66. Novartis AG Recent Developments
Table 67. Merck KGaA Company Details
Table 68. Merck KGaA Business Overview
Table 69. Merck KGaA Prion Disease Drug Product
Table 70. Merck KGaA Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 71. Merck KGaA Recent Developments
Table 72. Aurobindo Pharma Company Details
Table 73. Aurobindo Pharma Business Overview
Table 74. Aurobindo Pharma Prion Disease Drug Product
Table 75. Aurobindo Pharma Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 76. Aurobindo Pharma Recent Developments
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Prion Disease Drug Product
Table 80. AstraZeneca Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 81. AstraZeneca Recent Developments
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Prion Disease Drug Product
Table 85. Abbott Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 86. Abbott Recent Developments
Table 87. Ionis Pharmaceuticals Company Details
Table 88. Ionis Pharmaceuticals Business Overview
Table 89. Ionis Pharmaceuticals Prion Disease Drug Product
Table 90. Ionis Pharmaceuticals Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 91. Ionis Pharmaceuticals Recent Developments
Table 92. Lannett Company Details
Table 93. Lannett Business Overview
Table 94. Lannett Prion Disease Drug Product
Table 95. Lannett Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 96. Lannett Recent Developments
Table 97. Astellas Pharma Inc. Company Details
Table 98. Astellas Pharma Inc. Business Overview
Table 99. Astellas Pharma Inc. Prion Disease Drug Product
Table 100. Astellas Pharma Inc. Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 101. Astellas Pharma Inc. Recent Developments
Table 102. Sawai Pharmaceutical Company Details
Table 103. Sawai Pharmaceutical Business Overview
Table 104. Sawai Pharmaceutical Prion Disease Drug Product
Table 105. Sawai Pharmaceutical Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 106. Sawai Pharmaceutical Recent Developments
Table 107. Elite Pharmaceuticals, Inc. Company Details
Table 108. Elite Pharmaceuticals, Inc. Business Overview
Table 109. Elite Pharmaceuticals, Inc. Prion Disease Drug Product
Table 110. Elite Pharmaceuticals, Inc. Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 111. Elite Pharmaceuticals, Inc. Recent Developments
Table 112. Teva Pharmaceuticals Company Details
Table 113. Teva Pharmaceuticals Business Overview
Table 114. Teva Pharmaceuticals Prion Disease Drug Product
Table 115. Teva Pharmaceuticals Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 116. Teva Pharmaceuticals Recent Developments
Table 117. Bristol Myers Squibb Company Details
Table 118. Bristol Myers Squibb Business Overview
Table 119. Bristol Myers Squibb Prion Disease Drug Product
Table 120. Bristol Myers Squibb Revenue in Prion Disease Drug Business (2017-2022) & (US$ Million)
Table 121. Bristol Myers Squibb Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prion Disease Drug Market Share by Type: 2021 VS 2028
Figure 2. Antidepressant Features
Figure 3. Antipsychotic Agents Features
Figure 4. Others Features
Figure 5. Global Prion Disease Drug Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Others Case Studies
Figure 10. Prion Disease Drug Report Years Considered
Figure 11. Global Prion Disease Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Prion Disease Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Prion Disease Drug Market Share by Region: 2021 VS 2028
Figure 14. Global Prion Disease Drug Market Share by Players in 2021
Figure 15. Global Top Prion Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prion Disease Drug as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Prion Disease Drug Revenue in 2021
Figure 17. North America Prion Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Prion Disease Drug Market Size Market Share by Type (2017-2028)
Figure 19. North America Prion Disease Drug Market Size Market Share by Application (2017-2028)
Figure 20. North America Prion Disease Drug Market Size Share by Country (2017-2028)
Figure 21. United States Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Prion Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Prion Disease Drug Market Size Market Share by Type (2017-2028)
Figure 25. Europe Prion Disease Drug Market Size Market Share by Application (2017-2028)
Figure 26. Europe Prion Disease Drug Market Size Share by Country (2017-2028)
Figure 27. Germany Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Prion Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prion Disease Drug Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Prion Disease Drug Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Prion Disease Drug Market Size Share by Region (2017-2028)
Figure 37. China Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Prion Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Prion Disease Drug Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Prion Disease Drug Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Prion Disease Drug Market Size Share by Country (2017-2028)
Figure 47. Mexico Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Prion Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Prion Disease Drug Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Prion Disease Drug Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Prion Disease Drug Market Size Share by Country (2017-2028)
Figure 53. Turkey Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Prion Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Novartis AG Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 57. Merck KGaA Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 58. Aurobindo Pharma Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 59. AstraZeneca Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 60. Abbott Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 62. Lannett Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 63. Astellas Pharma Inc. Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 64. Sawai Pharmaceutical Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 65. Elite Pharmaceuticals, Inc. Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 67. Bristol Myers Squibb Revenue Growth Rate in Prion Disease Drug Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed